Measure Title: RELATING TO PRESCRIPTION DRUGS.
Report Title: Health Insurance; Prescription Drugs; Step Therapy Protocol; Clinical Review Criteria; Clinical Practice Guidelines; Exceptions
Description: Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.
Companion:  HB216
Package: None
Current Referral: HHS, CPN
Introducer(s): ELEFANTE, CHANG, DECOITE
Act:

Sort by Date Status Text
1/17/2025SReferred to HHS, CPN.
1/15/2025SIntroduced and passed First Reading.
1/13/2025SPending Introduction.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB226
All Versions of this Measure
Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.
Testimony
No testimony available at this time.
Hearing Notices
No hearings scheduled